Back to Editor profile » Dr Vaidyanathan

Dr Vaidyanathan

Dr Vaidyanathan

Consulting Editor - Venkatesh Vaidyanathan (PhD)

Teaching Assistant, University of Auckland, NZ 

Venkatesh defended his PhD (Molecular Medicine) thesis recently and has been working as a Teaching Assistant for the Department of Molecular Medicine and Pathology, University of Auckland. Venkatesh had the distinction of pursuing a thesis with publications. He did his masters in Genetechnology from Bharathidasan University, India. The thesis was well received and he was awarded a gold medal for his work.

Venkatesh has worked at Osmania University, Hyderabad in the capacity of a University Lecturer. He has taught theory and practical papers such as Medical Biotechnology, rDNA Technology and Molecular Biology to MSc (Biotechnology) students. As a University Lecturer, Venkatesh has had the rare opportunity of setting up a plant tissue culture laboratory, and an environmental biotechnology laboratory. He was also instrumental in designing summer projects for graduate students as well.

Venkatesh has worked on a wide variety of projects dealing with various human diseases ranging from endometriosis, fibroids, autism, and fungal sinusitis. The highlight of Venkatesh's position was that he worked in collaboration with clinicians, thus helping him understand the prognosis of the various diseases from a clinician's point of view too.

Venkatesh is currently working at the Faculty of Medical and Health Science on "Genetic and genomic technologies, and survival from prostate cancer". It is worthy of mention that he was shortlisted for “Young Researcher Award” by the New Zealand Society for Oncology (NZSO), 2016 for his contributions and invited to deliver a talk in their annual meeting.

Venkatesh has been pursuing the role of gene x environment, gene x diet, and gene x age interactions and the risk of aggressive prostate cancer in recent years. He has been speaking in various Conferences and Annual Meetings to promote the role of nutrigenomics and risk of aggressive prostate cancer in New Zealand population.